AUSTIN, Texas and TOKYO, Oct. 3, 2025 /PRNewswire/ -- According to DataM Intelligence, the Active Pharmaceutical Ingredients Market Size reached US$ 238.7 Billion in 2024, up from US$ 224.7 Billion in ...
The traditional APIs segment accounted for the largest share in 2024, whereas the HPAPI segment is expected to grow at the fastest CAGR over the forecast period. The HPAPI segment is further segmented ...
New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Pharmaceutical API Manufacturing Global Market Report 2023" - https ...
North America accounted for the largest share, 43.1%, of the active pharmaceutical ingredients (API) market in 2025. This dominance is driven by the presence of established pharmaceutical and API ...
QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...
SHAOXING, ZHEJIANG, CHINA, October 30, 2026 /EINPresswire.com/ -- The global pharmaceutical industry continues to show ...
ANKLESHWAR, India--(BUSINESS WIRE)--RUSAN PHARMA PRIVATE LIMITED, a pharmaceutical company based in India specializing in the area of addiction treatment and pain management, recently announced that ...
AbbVie’s North Chicago expansion adds two state-of-the-art API plants intended to support next-generation neuroscience and obesity portfolios via advanced manufacturing technologies and artificial ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
Luxembourg-based C2 Pharma, which already has a manufacturing agreement with Laurus Labs in India, has now bought a new supply of digoxin API. (Lauras Labs) () C2 Pharma, which concentrates on hard-to ...
India’s Torrent Pharma, which has been beefing up its international focused production capabilities, is buying an API operation from another Indian player. The Ahmedabad-based drugmaker today reported ...
Shanghai Pharmaceuticals has offered to acquire a majority stake, later to be followed by 100% ownership, in Changzhou Kony Pharma, a manufacturer of active pharmaceutical ingredients (APIs). Shanghai ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results